{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:23:50Z","timestamp":1782602630602,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cardfail.2017.03.001","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T19:33:16Z","timestamp":1489001596000},"page":"597-605","source":"Crossref","is-referenced-by-count":38,"title":["Feasibility and Association of Neurohumoral Blocker Up-titration After Cardiac Resynchronization Therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Pieter","family":"Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik H.","family":"Verbrugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Nijst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe B.","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson H.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2017.03.001_bib0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. SOLVD Investigators","volume":"325","author":"SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0020","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/CVM-2-1-020","article-title":"The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial","volume":"2","author":"Eichhorn","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"issue":"Suppl 5","key":"10.1016\/j.cardfail.2017.03.001_bib0035","first-page":"V30","article-title":"The mortality effect of metoprolol CR\/XL in patients with heart failure: results of the MERIT-HF trial","volume":"22","author":"Goldstein","year":"1999","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0040","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0045","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCHEARTFAILURE.109.912683","article-title":"Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF","volume":"3","author":"Heywood","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ejhf.510","article-title":"Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey","volume":"18","author":"Komajda","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0055","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0060","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0065","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amjcard.2011.03.060","article-title":"Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy","volume":"108","author":"Mullens","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0075","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"10.1016\/j.cardfail.2017.03.001_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009889.pub2","article-title":"Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction","author":"Driscoll","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0090","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/eurheartj\/eht514","article-title":"Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy","volume":"35","author":"Schmidt","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0095","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.amjcard.2012.01.387","article-title":"Relation of dosing of the renin-angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis","volume":"109","author":"Mantziari","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0100","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1161\/CIRCULATIONAHA.110.955039","article-title":"Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy","volume":"122","author":"Solomon","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0105","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/eurjhf\/hfs175","article-title":"Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy","volume":"15","author":"Fiuzat","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0115","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/clc.20500","article-title":"Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy","volume":"33","author":"Voigt","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/AC.66.5.2131081","article-title":"Cardiac Resynchronization in Combination With Beta Blocker Treatment in Advanced Chronic Heart Failure (CARIBE-HF): the results of the CARIBE-HF study","volume":"66","author":"Grosu","year":"2011","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.cardfail.2017.03.001_bib0125","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.cardfail.2016.09.023","article-title":"Mode of death in octogenarians treated with cardiac resynchronization therapy","volume":"22","author":"Martens","year":"2016","journal-title":"J Card Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916417300581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916417300581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T18:55:12Z","timestamp":1536000912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916417300581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1071916417300581"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2017.03.001","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}